5 results match your criteria: "Osaka Univ. Hosp.[Affiliation]"
Clin Chem
December 1996
Central Lab. for Clin. Invest., Osaka Univ. Hosp., Japan.
Clin Chem
February 1996
Central Lab. for Clin. Investigation, Osaka Univ. Hosp., Japan.
Clin Chem
April 1995
Central Lab. for Clin. Invest., Osaka Univ. Hosp., Japan.
Int J Oncol
November 1994
SHIGA UNIV MED SCI,DEPT ANESTHESIOL,OTSU,SHIGA 52021,JAPAN. OSAKA MED CTR MATERNAL & CHILD HLTH,OSAKA 59002,JAPAN. OSAKA UNIV HOSP,DEPT INTERNAL MED 3,SUITA,OSAKA 565,JAPAN.
We have previously shown that growth enhancement of murine transformed Leydig cells (B-1F) by estrogen is partly mediated through inhibition of leukotriene formation due to suppression of 5-lipoxygenase activity; leukotrienes, which inhibit the proliferation of B-1F cells, play an important role in an autocrine loop for B-1F cells to proliferate in an estrogen-sensitive manner. An estrogen-insensitive cell line, termed Cl 4(-), was established from B-1F cells and maintained in serum-free culture medium without addition of estrogen. The proliferation of Cl 4(-) cells was not affected by the addition of 10(-11)-10(-6) M 17 beta-estradiol, whereas an estrogen receptor in Cl 4(-) cells appeared to be normal, as judged by its binding to estrogens.
View Article and Find Full Text PDFClin Chem
July 1992
Central Lab. for Clin. Investigation, Osaka Univ. Hosp., Japan.